Abstract molecular signaling network with AI computational layers — Zermatt AI Platform
Platform

AI Platform for
Mechanistic Disease Modeling

Built to decode signaling pathways and accelerate therapeutic discovery.

How the Platform Works

A four-stage workflow connecting raw multi-omics data to ranked therapeutic targets.

01 / DATA
Data
Multi-omics data ingestion — RNA-seq, proteomics, patient cohort phenotypes.
02 / MODEL
Model
Pathway inference — graph neural networks learn signaling topology from data.
03 / BIOLOGY
Biology
Causal network modeling — identify root-cause drivers of disease state.
04 / TARGETS
Drug Targets
Target prioritization — rank by druggability, mechanism, and translational potential.

Platform Outputs

Four classes of deliverable for partners and internal programs.

Disease mechanism maps

Causal network diagrams showing how genetic dysregulation propagates into clinical phenotype.

Target ranking

Ranked target lists scored on mechanism centrality, druggability, and tractability.

Biomarker discovery

Candidate biomarkers for trial enrichment and pharmacodynamic readout.

Patient stratification

Hypotheses for which mechanism subgroups will respond to which therapy.

Example Visualization

A live mechanism map of AGS-driving signaling — what partners see inside the platform.

Zermatt Platform · AGS Workspace

Live mechanism map of AGS-driving signaling — interactive in product. Hover any node above.

See it in action

Request a 30-minute walkthrough with our team — we'll show the platform live on your disease of interest.